Clinical trial
Efficacy of Artemether/Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Children Five Years After Wide Scale Use of the Drug in Tanzania.
NCT02089841 is registered in ClinicalTrials.gov with Richard Mwaiswelo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Artemether/Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Children Five Years After Wide Scale Use of the Drug in Tanzania.
- Lead sponsor
- Richard Mwaiswelo
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2012
- Completion date
- August 31, 2013
- Enrollment
- 140 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
plasmodium falciparum malaria